{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T06:55:56Z","timestamp":1781592956437,"version":"3.54.5"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,15]]},"DOI":"10.7759\/cureus.110938","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T06:31:42Z","timestamp":1781591502000},"source":"Crossref","is-referenced-by-count":0,"title":["MicroRNA Signatures in Cardiovascular Diseases: A Systematic Literature Review"],"prefix":"10.7759","author":[{"given":"Hariballav","family":"Mahapatra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaj","family":"Banotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand","family":"Sekar G","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jignesh","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharat","family":"Vishwanath K","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh","family":"Tripathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.4274\/balkanmedj.galenos.2020.2020.1.94","article-title":"MicroRNA and cardiovascular diseases","volume":"37","author":"\u00c7akmak HA","year":"2020","unstructured":"\u00c7akmak HA, Demir M. MicroRNA and cardiovascular diseases. Balkan Med J. 2020, 37:60-71. 10.4274\/balkanmedj.galenos.2020.2020.1.94","journal-title":"Balkan Med J"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2016-0576","article-title":"microRNAs in cardiovascular disease - clinical application","volume":"55","author":"Schulte C","year":"2017","unstructured":"Schulte C, Karakas M, Zeller T. microRNAs in cardiovascular disease - clinical application. Clin Chem Lab Med. 2017, 55:687-704. 10.1515\/cclm-2016-0576","journal-title":"Clin Chem Lab Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2017.00074","article-title":"microRNA in cardiovascular aging and age-related cardiovascular diseases","volume":"4","author":"de Lucia C","year":"2017","unstructured":"de Lucia C, Komici K, Borghetti G, et al.. microRNA in cardiovascular aging and age-related cardiovascular diseases. Front Med (Lausanne). 2017, 4:74. 10.3389\/fmed.2017.00074","journal-title":"Front Med (Lausanne)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s11886-023-02014-1","article-title":"MicroRNAs and cardiovascular disease risk","volume":"26","author":"Searles CD","year":"2024","unstructured":"Searles CD. MicroRNAs and cardiovascular disease risk. Curr Cardiol Rep. 2024, 26:51-60. 10.1007\/s11886-023-02014-1","journal-title":"Curr Cardiol Rep"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.09.945","article-title":"MicroRNAs in cardiovascular disease","volume":"68","author":"Barwari T","year":"2016","unstructured":"Barwari T, Joshi A, Mayr M. MicroRNAs in cardiovascular disease. J Am Coll Cardiol. 2016, 68:2577-84. 10.1016\/j.jacc.2016.09.945","journal-title":"J Am Coll Cardiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvw174","article-title":"Identifying circulating microRNAs as biomarkers of cardiovascular disease: a systematic review","volume":"111","author":"Navickas R","year":"2016","unstructured":"Navickas R, Gal D, Laucevi\u010dius A, Taparauskait\u0117 A, Zdanyt\u0117 M, Holvoet P. Identifying circulating microRNAs as biomarkers of cardiovascular disease: a systematic review. Cardiovasc Res. 2016, 111:322-37. 10.1093\/cvr\/cvw174","journal-title":"Cardiovasc Res"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.yjmcc.2017.03.005","article-title":"Translating the microRNA signature of microvesicles derived from human coronary artery smooth muscle cells in patients with familial hypercholesterolemia and coronary artery disease","volume":"106","author":"de Gonzalo-Calvo D","year":"2017","unstructured":"de Gonzalo-Calvo D, Cenarro A, Garlaschelli K, et al.. Translating the microRNA signature of microvesicles derived from human coronary artery smooth muscle cells in patients with familial hypercholesterolemia and coronary artery disease. J Mol Cell Cardiol. 2017, 106:55-67. 10.1016\/j.yjmcc.2017.03.005","journal-title":"J Mol Cell Cardiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.24428","article-title":"Cardiovascular disease-related miRNAs expression: potential role as biomarkers and effects of training exercise","volume":"9","author":"Ultimo S","year":"2018","unstructured":"Ultimo S, Zauli G, Martelli AM, Vitale M, McCubrey JA, Capitani S, Neri LM. Cardiovascular disease-related miRNAs expression: potential role as biomarkers and effects of training exercise. Oncotarget. 2018, 9:17238-54. 10.18632\/oncotarget.24428","journal-title":"Oncotarget"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcm.2016.02.004","article-title":"MicroRNA: a new therapeutic strategy for cardiovascular diseases","volume":"26","author":"Samanta S","year":"2016","unstructured":"Samanta S, Balasubramanian S, Rajasingh S, Patel U, Dhanasekaran A, Dawn B, Rajasingh J. MicroRNA: a new therapeutic strategy for cardiovascular diseases. Trends Cardiovasc Med. 2016, 26:407-19. 10.1016\/j.tcm.2016.02.004","journal-title":"Trends Cardiovasc Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/aps.2018.30","article-title":"miRNAS in cardiovascular diseases: potential biomarkers, therapeutic targets and challenges","volume":"39","author":"Zhou SS","year":"2018","unstructured":"Zhou SS, Jin JP, Wang JQ, Zhang ZG, Freedman JH, Zheng Y, Cai L. miRNAS in cardiovascular diseases: potential biomarkers, therapeutic targets and challenges. Acta Pharmacol Sin. 2018, 39:1073-84. 10.1038\/aps.2018.30","journal-title":"Acta Pharmacol Sin"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/aps.2018.35","article-title":"The circulating non-coding RNA landscape for biomarker research: lessons and prospects from cardiovascular diseases","volume":"39","author":"E S","year":"2018","unstructured":"E S, Costa MC, Kurc S, Dro\u017cd\u017c A, Cortez-Dias N, Enguita FJ. The circulating non-coding RNA landscape for biomarker research: lessons and prospects from cardiovascular diseases. Acta Pharmacol Sin. 2018, 39:1085-99. 10.1038\/aps.2018.35","journal-title":"Acta Pharmacol Sin"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/jcdd8020022","article-title":"Role of selected miRNAs as diagnostic and prognostic biomarkers in cardiovascular diseases, including coronary artery disease, myocardial infarction and atherosclerosis","volume":"8","author":"Mir R","year":"2021","unstructured":"Mir R, Elfaki I, Khullar N, et al.. Role of selected miRNAs as diagnostic and prognostic biomarkers in cardiovascular diseases, including coronary artery disease, myocardial infarction and atherosclerosis. J Cardiovasc Dev Dis. 2021, 8:10.3390\/jcdd8020022","journal-title":"J Cardiovasc Dev Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3390\/cells8070737","article-title":"MicroRNAs in cardiac diseases","volume":"8","author":"Colpaert RM","year":"2019","unstructured":"Colpaert RM, Calore M. MicroRNAs in cardiac diseases. Cells. 2019, 8:10.3390\/cells8070737","journal-title":"Cells"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-017-1176-x","article-title":"Specific circulating microRNA signature of bicuspid aortic valve disease","volume":"15","author":"Mart\u00ednez-Micaelo N","year":"2017","unstructured":"Mart\u00ednez-Micaelo N, Beltr\u00e1n-Deb\u00f3n R, Baiges I, Faiges M, Alegret JM. Specific circulating microRNA signature of bicuspid aortic valve disease. J Transl Med. 2017, 15:76. 10.1186\/s12967-017-1176-x","journal-title":"J Transl Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies","volume":"155","author":"Whiting PF","year":"2011","unstructured":"Whiting PF, Rutjes AW, Westwood ME, et al.. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011, 155:529-36. 10.7326\/0003-4819-155-8-201110180-00009","journal-title":"Ann Intern Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang A","year":"2010","unstructured":"Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010, 25:603-5. 10.1007\/s10654-010-9491-z","journal-title":"Eur J Epidemiol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.123.033674","article-title":"Plasma extracellular microRNAs associated with cardiovascular disease risk factors in middle-aged and older adults","volume":"13","author":"Karlin H","year":"2024","unstructured":"Karlin H, Sooda M, Larson M, et al.. Plasma extracellular microRNAs associated with cardiovascular disease risk factors in middle-aged and older adults. J Am Heart Assoc. 2024, 13:e033674. 10.1161\/JAHA.123.033674","journal-title":"J Am Heart Assoc"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-024-00690-x","article-title":"Global surveillance of circulating microRNA for diagnostic and prognostic assessment of acute myocardial infarction based on the plasma small RNA sequencing","volume":"12","author":"Wang X","year":"2024","unstructured":"Wang X, Lu Y, Zhao R, et al.. Global surveillance of circulating microRNA for diagnostic and prognostic assessment of acute myocardial infarction based on the plasma small RNA sequencing. Biomark Res. 2024, 12:143. 10.1186\/s40364-024-00690-x","journal-title":"Biomark Res"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-025-11060-7","article-title":"Circulating plasma microRNA expression profile: potential minimally invasive biomarker for early detection of coronary artery disease development","volume":"52","author":"Kana\u0161niece E","year":"2025","unstructured":"Kana\u0161niece E, Dauk\u0161aite V, Vilne B, Gail\u012bte L, Caun\u012bte L, \u0112rglis A, Tru\u0161inskis K. Circulating plasma microRNA expression profile: potential minimally invasive biomarker for early detection of coronary artery disease development. Mol Biol Rep. 2025, 52:927. 10.1007\/s11033-025-11060-7","journal-title":"Mol Biol Rep"},{"key":"ref20","article-title":"Plasma circulating microRNAs in patients with stable coronary artery disease - Impact of different cardiovascular risk profiles and glomerular filtration rates","volume":"7","author":"Trusinskis K","year":"2021","unstructured":"Trusinskis K, Lapsovs M, Paeglite S, et al.. Plasma circulating microRNAs in patients with stable coronary artery disease - Impact of different cardiovascular risk profiles and glomerular filtration rates. J Clin Transl Res. 2021, 7:270-6.","journal-title":"J Clin Transl Res"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.4314\/ahs.v21i2.31","article-title":"Circulatory microRNA expression profile for coronary artery calcification in chronic kidney disease patients","volume":"21","author":"Vijayaraghavan B","year":"2021","unstructured":"Vijayaraghavan B, Jeyamohan S, Padmanabhan G, Velangann AJ, Ramanathan K. Circulatory microRNA expression profile for coronary artery calcification in chronic kidney disease patients. Afr Health Sci. 2021, 21:728-34. 10.4314\/ahs.v21i2.31","journal-title":"Afr Health Sci"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-03042-3","article-title":"MicroRNA signature predicts post operative atrial fibrillation after coronary artery bypass grafting","volume":"15","author":"Yerukala Sathipati S","year":"2025","unstructured":"Yerukala Sathipati S, Carter T, Soodi D, et al.. MicroRNA signature predicts post operative atrial fibrillation after coronary artery bypass grafting. Sci Rep. 2025, 15:18658. 10.1038\/s41598-025-03042-3","journal-title":"Sci Rep"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1093\/ejcts\/ezw245","article-title":"Elevated serum microRNA 483-5p levels may predict patients at risk of post-operative atrial fibrillation","volume":"51","author":"Harling L","year":"2017","unstructured":"Harling L, Lambert J, Ashrafian H, Darzi A, Gooderham NJ, Athanasiou T. Elevated serum microRNA 483-5p levels may predict patients at risk of post-operative atrial fibrillation. Eur J Cardiothorac Surg. 2017, 51:73-8. 10.1093\/ejcts\/ezw245","journal-title":"Eur J Cardiothorac Surg"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26189076","article-title":"Comprehensive profiling identifies circulating microRNA dysregulation in Vietnamese patients with heart failure","volume":"26","author":"Vu BQ","year":"2025","unstructured":"Vu BQ, Huynh PA, Nguyen NN, et al.. Comprehensive profiling identifies circulating microRNA dysregulation in Vietnamese patients with heart failure. Int J Mol Sci. 2025, 26:10.3390\/ijms26189076","journal-title":"Int J Mol Sci"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.15324","article-title":"Multi-microRNA diagnostic panel for heart failure with preserved ejection fraction in preclinical and clinical settings","volume":"12","author":"Parvan R","year":"2025","unstructured":"Parvan R, Rolim N, Gevaert AB, et al.. Multi-microRNA diagnostic panel for heart failure with preserved ejection fraction in preclinical and clinical settings. ESC Heart Fail. 2025, 12:3028-41. 10.1002\/ehf2.15324","journal-title":"ESC Heart Fail"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.121.001251","article-title":"Empagliflozin improves the microRNA signature of endothelial dysfunction in patients with heart failure with preserved ejection fraction and diabetes","volume":"384","author":"Mone P","year":"2023","unstructured":"Mone P, Lombardi A, Kansakar U, et al.. Empagliflozin improves the microRNA signature of endothelial dysfunction in patients with heart failure with preserved ejection fraction and diabetes. J Pharmacol Exp Ther. 2023, 384:116-22. 10.1124\/jpet.121.001251","journal-title":"J Pharmacol Exp Ther"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-026-42550-8","article-title":"A circulating MicroRNA signature for the diagnosis of pulmonary arterial hypertension and functional characterization of candidate miR-3168","volume":"16","author":"Lago-Docampo M","year":"2026","unstructured":"Lago-Docampo M, Iglesias-L\u00f3pez A, Vilari\u00f1o C, Baloira A, Barber\u00e1 JA, Blanco I, Valverde D. A circulating MicroRNA signature for the diagnosis of pulmonary arterial hypertension and functional characterization of candidate miR-3168. Sci Rep. 2026, 16:10.1038\/s41598-026-42550-8","journal-title":"Sci Rep"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1172\/JCI159179","article-title":"MicroRNAs as therapeutic targets in cardiovascular disease","volume":"132","author":"Laggerbauer B","year":"2022","unstructured":"Laggerbauer B, Engelhardt S. MicroRNAs as therapeutic targets in cardiovascular disease. J Clin Invest. 2022, 132:10.1172\/JCI159179","journal-title":"J Clin Invest"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.3390\/biom10101354","article-title":"Circulating microRNA as a biomarker for coronary artery disease","volume":"10","author":"Fazmin IT","year":"2020","unstructured":"Fazmin IT, Achercouk Z, Edling CE, Said A, Jeevaratnam K. Circulating microRNA as a biomarker for coronary artery disease. Biomolecules. 2020, 10:10.3390\/biom10101354","journal-title":"Biomolecules"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1113\/EP087469","article-title":"Insufficient sleep is associated with a pro-atherogenic circulating microRNA signature","volume":"104","author":"Hijmans JG","year":"2019","unstructured":"Hijmans JG, Levy M, Garcia V, et al.. Insufficient sleep is associated with a pro-atherogenic circulating microRNA signature. Exp Physiol. 2019, 104:975-82. 10.1113\/EP087469","journal-title":"Exp Physiol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1161\/HCG.0000000000000062","article-title":"Noncoding RNAs in cardiovascular disease: current knowledge, tools and technologies for investigation, and future directions: a scientific statement from the American Heart Association","volume":"13","author":"Das S","year":"2020","unstructured":"Das S, Shah R, Dimmeler S, et al.. Noncoding RNAs in cardiovascular disease: current knowledge, tools and technologies for investigation, and future directions: a scientific statement from the American Heart Association. Circ Genom Precis Med. 2020, 13:e000062. 10.1161\/HCG.0000000000000062","journal-title":"Circ Genom Precis Med"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2018.06.010","article-title":"MicroRNA signatures in cardiac biopsies and detection of allograft rejection","volume":"37","author":"Di Francesco A","year":"2018","unstructured":"Di Francesco A, Fedrigo M, Santovito D, et al.. MicroRNA signatures in cardiac biopsies and detection of allograft rejection. J Heart Lung Transplant. 2018, 37:1329-40. 10.1016\/j.healun.2018.06.010","journal-title":"J Heart Lung Transplant"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.109529","article-title":"The role of hydrogen sulfide in the pathophysiology and therapeutic modulation of hypertension: a scoping review","volume":"18","author":"Nikolov NN","year":"2026","unstructured":"Nikolov NN, Yambolov SN, Grigorov RK, Yankov YG. The role of hydrogen sulfide in the pathophysiology and therapeutic modulation of hypertension: a scoping review. Cureus. 2026, 18:109529. 10.7759\/cureus.109529","journal-title":"Cureus"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/500847-microrna-signatures-in-cardiovascular-diseases-a-systematic-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T06:31:43Z","timestamp":1781591503000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/500847-microrna-signatures-in-cardiovascular-diseases-a-systematic-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,15]]},"references-count":33,"URL":"https:\/\/doi.org\/10.7759\/cureus.110938","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,15]]}}}